1. Home
  2. RJF vs NTRA Comparison

RJF vs NTRA Comparison

Compare RJF & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Raymond James Financial Inc.

RJF

Raymond James Financial Inc.

HOLD

Current Price

$170.76

Market Cap

32.5B

Sector

Finance

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$242.39

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RJF
NTRA
Founded
1962
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.5B
27.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
RJF
NTRA
Price
$170.76
$242.39
Analyst Decision
Hold
Strong Buy
Analyst Count
11
15
Target Price
$182.91
$249.53
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
01-28-2026
02-26-2026
Dividend Yield
1.27%
N/A
EPS Growth
6.19
N/A
EPS
10.30
N/A
Revenue
$14,015,000,000.00
$2,116,676,000.00
Revenue This Year
$14.72
$33.42
Revenue Next Year
$5.60
$16.96
P/E Ratio
$16.51
N/A
Revenue Growth
9.52
38.17
52 Week Low
$117.57
$125.38
52 Week High
$177.66
$256.36

Technical Indicators

Market Signals
Indicator
RJF
NTRA
Relative Strength Index (RSI) 56.77 57.64
Support Level $165.41 $226.66
Resistance Level $174.70 $243.03
Average True Range (ATR) 4.32 9.85
MACD 0.18 -0.59
Stochastic Oscillator 71.05 56.59

Price Performance

Historical Comparison
RJF
NTRA

About RJF Raymond James Financial Inc.

Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalogue of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenues and earnings through a vast network of nearly 8,800 independent and employee-affiliated advisors, who collectively manage over $1.7 trillion in client assets as of fiscal year-end 2025. While Raymond James maintains a global footprint, the company derives over 90% of its revenue, and an even larger percentage of its operating income, from the United States.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: